Pregnancy Loss, Recurrent, Susceptibility To, 1; Rprgl1

Description

Miscarriage, the commonest complication of pregnancy, is the spontaneous loss of a pregnancy before the fetus has reached viability. The term therefore includes all pregnancy losses from the time of conception until 24 weeks of gestation. Recurrent miscarriage, defined as 3 or more consecutive pregnancy losses, affects about 1% of couples; when defined as 2 or more losses, the scale of the problem increases to 5% of all couples trying to conceive (summary by Rai and Regan, 2006).Pregnancy losses have traditionally been designated 'spontaneous abortions' if they occur before 20 weeks gestation and 'stillbirths' if they occur after 20 weeks. Subtypes of spontaneous abortions can be further distinguished on the basis of embryonic development and include anembryonic loss in the first 5 weeks after conception (so-called 'blighted ovum'), embryonic loss from 6 to 9 weeks' gestation, and fetal loss from 10 weeks' gestation through the remainder of the pregnancy. These distinctions are important because the causes of pregnancy loss vary over gestational ages, with anembryonic losses being more likely to be associated with chromosomal abnormalities, for example. Possible etiologies for RPRGL include uterine anatomic abnormalities, cytogenetic abnormalities in the parents or fetus, single gene disorders, thrombophilic conditions, and immunologic or endocrine factors as well as environmental or infectious agents (summary by Warren and Silver, 2008). Genetic Heterogeneity of Recurrent Pregnancy LossSusceptibility to RPRGL2 (OMIM ) is conferred by mutation in the coagulation factor II gene (OMIM ) on chromosome 11p11; RPRGL3 (OMIM ) by mutation in the ANXA5 gene (OMIM ) on chromosome 4q27; and RPRGL4 (see {270960}) by mutation in the SYCP3 gene (OMIM ) on chromosome 12q23.Genetic variation in the conceptus itself that results in decreased viability of the embryo or fetus is discussed in the respective gene and/or phenotype entry (see, e.g., MTHFR, {607093.0004}; NLRP7, {609661}; hydatidiform mole, {231090}).

Clinical Features

Phenotypes and symptoms related to Pregnancy Loss, Recurrent, Susceptibility To, 1; Rprgl1

  • Nevus
  • Spontaneous abortion
  • Recurrent spontaneous abortion

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Pregnancy Loss, Recurrent, Susceptibility To, 1; Rprgl1 Is also known as embryonic loss, recurrent, fetal loss, recurrent, susceptibility to, rprgl, rpl, miscarriage, recurrent, abortion, spontaneous, recurrent, stillbirth, recurrent.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Pregnancy Loss, Recurrent, Susceptibility To, 1; Rprgl1 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
F5.

By Molecular Diagnostic Laboratory University of Alberta (Canada).

F5
Specificity
100 %
Genes
100 %
Factor V Leiden Mutation Panel.

By Baylor Miraca Genetics Laboratories (United States).

F5
Specificity
100 %
Genes
100 %
Thrombophilia Mutation Panel.

By Baylor Miraca Genetics Laboratories (United States).

F2, F5, MTHFR
Specificity
34 %
Genes
100 %
Factor V Leiden.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

F5
Specificity
100 %
Genes
100 %
Factor V Leiden.

By Center for Human Genetics, Inc (United States).

F5
Specificity
100 %
Genes
100 %
Factor V Leiden Thrombophilia.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).

F5
Specificity
100 %
Genes
100 %
Factor V Analysis.

By Molecular Pathology Laboratory University of Pennsylvania Health System (United States).

F5
Specificity
100 %
Genes
100 %
Factore V Leiden.

By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).

F5
Specificity
100 %
Genes
100 %

You can get up to 99 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHASHI-PENA SYNDROME; SHAPNS X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME SEPTO-OPTIC DYSPLASIA SPECTRUM VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1 PERLMAN SYNDROME; PRLMNS MUSCULAR DYSTROPHY, BECKER TYPE; BMD